Physician profile
John Mcauley
NPI 1104812619
$1,853.99
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $822 · 2020: $574 · 2021: $281 · 2022: $112 · 2023: $19.44 · 2024: $45.44.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $64.88.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $64.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $317.20 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $293.53 | 2019-2021 | |
| Amgen INC. | $224.28 | 2019-2021 | |
| Abbott Laboratories | $202.50 | 2020-2024 | Freestyle Libre |
| Abbvie INC. | $159.62 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $137.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.87 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $72.65 | 2019-2021 | |
| Pfizer INC. | $51.05 | 2019-2020 | |
| Allergan, INC. | $50.31 | 2019-2020 | |
| Lilly USA, LLC | $38.74 | 2019-2020 | |
| Avanir Pharmaceuticals, INC. | $37.35 | 2019 | |
| Almatica Pharma LLC | $28.21 | 2024 | Loreev Xr |
| Sanofi-Aventis U.S. LLC | $24.17 | 2019 | |
| Astellas Pharma US INC | $20.41 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.66 | 2019 | |
| Glaxosmithkline, LLC. | $14.68 | 2021 | |
| Genentech USA, INC. | $13.93 | 2022 | |
| Esperion Therapeutics, INC. | $13.74 | 2020 | |
| Eisai INC. | $13.73 | 2020 | |
| Mylan Specialty L.P. | $13.01 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $11.44 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcauley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.